ATLANTA, GA – – (Globe Newswire – February 24, 2026) – – A shareholder class action lawsuit has been filed against Zynex, Inc. (“Zynex” or the “Company”) (OTCMKTS: ZYXIQ). The lawsuit alleges that Defendants issued false and misleading statements and/or failed to disclose material adverse facts regarding Zynex’s business, operations, and prospects, including allegations that:  (1) Zynex shipped products, including electrodes, in excess of need; (2) as a result of this practice, the Company inflated its revenue; and (3) the Company’s practice of filing false claims drew scrutiny from insurers, including Tricare; and (4) the Company’s order growth was a result of illegal overbilling.

If you purchased Zynex shares between February 25, 2021 and December 15, 2025, and experienced a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832, or by visiting the firm’s website at www.holzerlaw.com/case/zynex/ for more information.

The deadline to ask the court to be appointed lead plaintiff in the case is April 21, 2026.